Medicare Compliance & Reimbursement
Chemotherapy Reimbursement Not Covering $144 Million Cost
Chemotherapy administration payments were nearly 50 percent less than practice expenses in oncology practices, according to study data presented by the Washington-based Moran Company. Not only that, but on average the Resource-Based Relative Value System (RBRVS) only reimburses physicians for 70 percent of the cost of treating Medicare patients, the study found.
This happens because Medicare "blends" practice expenses across specialties and thus factors out specialty-specific expenses, the Moran study explained. Moran is also conducting a second study on the changes in oncology practices in 2005. The National Patient Advocate Foundation commissioned both studies and presented the data it's already received from Moran at a Feb. 17 meeting with the Centers for Medicare and Medicaid Services.
A second study, performed for the NPAF by the University of Utah's Pharmacotherapy Outcomes Research Center, found that preparing a chemotherapy dose costs physicians on average $36.03. Multiplied by the total number of chemotherapy infusions per year, this adds up to $144 million per year, the study noted.
Medicare Compliance & Reimbursement
- Health Plans:
CMS Happy With Local Medicare Plan Applications
But are regional plan numbers a bad omen for rural patients?
The Centers for Medicare and [...] - Health Spending:
Expect Scrutiny Of Health Prices As Spending Continues Upward
Growth rate is considerably higher than projected growth for the U.S. economy overall
On average, [...] - Long-Term Care:
Providers May Have To Swallow Costlier Meds In 2006
Upside: New HEDIS standards say drugs shouldn't have been included in the first place
The [...] - Legislation:
States Struggling For Ways To Cover Working Uninsured
Medicaid threatened by decline in employer coverage for lower-income workers
Even as states and the [...] - Physicians:
Chemotherapy Reimbursement Not Covering $144 Million Cost
If oncology practices feel short-changed, it may be for a reason
Chemotherapy administration payments were nearly [...] - Laboratories:
Its Time To Ramp Up Diabetes Screening Tests
Now labs can bill at least once per year for all patients
The Medicare Modernization Act [...] - DME:
Share Power Mobility Denial Pain With CMS
Region B represents a particular problem, some suppliers say
Frustrated over inexplicable denials of power mobility [...] - Home Health:
CMS Whittles Home Health Compare Measures To 10
Risk adjustment problems keep 5 NQF-endorsed standards on the sidelines.
Home health providers won't have to [...] - Enforcement:
Don't Let Networking Weave A Tangled Web
Watch for tactics that build provider alliances-but sabotage compliance
The owner of several Miami, FL durable [...] - Long-Term Care:
How CMS Plans To Make Staffing Choices Safer
OIG: Nurse aid registries are coming up short on the facts
Facilities that rely on state [...] - BILL WATCH
The following bills were introduced in the Senate: S. 437. A bill to amend titles [...]
